Abstract | OBJECTIVE: To evaluate the performance of a line blot (LB) assay for identifying anti-PM-Scl antibody (Ab). METHODS: We screened 56 serum samples from systemic sclerosis patients using a protein immunoprecipitation (IP) assay and an LB assay ( Systemic Sclerosis Profile Euroline® Blot test kit) to detect anti-PM-Scl Ab. We compared the results obtained by the IP and LB assays. RESULTS: Among the 56 serum samples of SSc patients, 9 sera were positive for anti-PM-Scl75 Ab and 1 for anti-PM-Scl100 Ab by the LB assay. The protein IP assay revealed that none of the samples precipitated 75 or 100 kDa proteins identical to the anti-PM-Scl Ab reference serum, regardless of the positive or negative results obtained in the LB assay. Therefore, the false-positive rates for both anti-PM-Scl75 Ab and anti-PM-Scl100 Ab by the LB assay were 100%. CONCLUSION: Detection of anti-PM-Scl Ab assessed with a commercial LB assay requires extreme caution since it may yield false-positive data.
|
Authors | Yasuhito Hamaguchi, Masataka Kuwana, Kazuhiko Takehara |
Journal | International journal of rheumatic diseases
(Int J Rheum Dis)
Vol. 22
Issue 9
Pg. 1746-1751
(Sep 2019)
ISSN: 1756-185X [Electronic] England |
PMID | 31245910
(Publication Type: Comparative Study, Evaluation Study, Journal Article)
|
Copyright | © 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd. |
Chemical References |
- Autoantibodies
- Biomarkers
- EXOSC9 protein, human
- RNA-Binding Proteins
- Exoribonucleases
- Exosome Multienzyme Ribonuclease Complex
- EXOSC10 protein, human
|
Topics |
- Autoantibodies
(blood)
- Biomarkers
(blood)
- Exoribonucleases
(immunology)
- Exosome Multienzyme Ribonuclease Complex
(immunology)
- False Positive Reactions
- Humans
- Immunologic Tests
- Japan
- Predictive Value of Tests
- RNA-Binding Proteins
(immunology)
- Reproducibility of Results
- Scleroderma, Systemic
(blood, diagnosis, immunology)
|